Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
mi
from
West Orange, NJ
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
West Orange, NJ
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
mi
from
Albany, NY
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Albany, NY
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
mi
from
Charlotte, NC
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Charlotte, NC
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
mi
from
Lima, OH
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Lima, OH
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
mi
from
Ponca City, OK
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Ponca City, OK
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
mi
from
Philadelphia, PA
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Philadelphia, PA
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
mi
from
Providence, RI
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Providence, RI
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
mi
from
Nashville, TN
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Nashville, TN
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
mi
from
Austin, TX
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Austin, TX
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
mi
from
Richmond, VA
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Richmond, VA
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
mi
from
Mountlake Terrace, WA
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Mountlake Terrace, WA
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
mi
from
Morgantown, WV
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Morgantown, WV
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
mi
from
Milwaukee, WI
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Biventricular Versus Right Ventricular Pacing in Heart Failure Patients With Atrioventricular Block (BLOCK HF)
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Milwaukee, WI
Anemia in Heart Failure With a Preserved Ejection Fraction (HFPEF)
Efficacy of Treating Anemia in Heart Failure With a Preserved Ejection Fraction (HFPEF) on Ventricular Function, Exercise Capacity and Health Status
Status: Archived
mi
from
New York, NY
Anemia in Heart Failure With a Preserved Ejection Fraction (HFPEF)
Efficacy of Treating Anemia in Heart Failure With a Preserved Ejection Fraction (HFPEF) on Ventricular Function, Exercise Capacity and Health Status
Status: Archived
Updated: 1/1/1970
Clinical Cardiovascular Research Laboratory for the Elderly
mi
from
New York, NY
Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart Disease
Compassionate Use of Deferiprone in Patients With Thalassemia and Iron-Induced Heart Disease
Status: Archived
mi
from
New Brunswick, NJ
Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart Disease
Compassionate Use of Deferiprone in Patients With Thalassemia and Iron-Induced Heart Disease
Status: Archived
Updated: 1/1/1970
Saint Peter's University Hospital
mi
from
New Brunswick, NJ
T Wave Alternans in Hemodialysis
Pilot Study of a Noninvasive Predictor of Sudden Cardiac Death in Hemodialysis Patients
Status: Archived
mi
from
Indianapolis, IN
T Wave Alternans in Hemodialysis
Pilot Study of a Noninvasive Predictor of Sudden Cardiac Death in Hemodialysis Patients
Status: Archived
Updated: 1/1/1970
Indiana Univeristy School of Medicine
mi
from
Indianapolis, IN
Exercise to Treat Depression in Individuals With Coronary Heart Disease
Understanding the Prognostic Benefits of Exercise and Anti-depressant Therapy (UPBEAT)
Status: Archived
mi
from
Durham, NC
Exercise to Treat Depression in Individuals With Coronary Heart Disease
Understanding the Prognostic Benefits of Exercise and Anti-depressant Therapy (UPBEAT)
Status: Archived
Updated: 1/1/1970
Duke Univ Med Ctr
mi
from
Durham, NC
Morphological Predictors of Sudden Cardiac Death in Patients With Known Cardiomyopathies
Morphological Predictors of Sudden Cardiac Death in Patients With Known Cardiomyopathies
Status: Archived
mi
from
Pittsburgh, PA
Morphological Predictors of Sudden Cardiac Death in Patients With Known Cardiomyopathies
Morphological Predictors of Sudden Cardiac Death in Patients With Known Cardiomyopathies
Status: Archived
Updated: 1/1/1970
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem
Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem
Status: Archived
mi
from
Chestnut Hill, MA
Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem
Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem
Status: Archived
Updated: 1/1/1970
Brigham & Women's Hospital Women's Health Center
mi
from
Chestnut Hill, MA
Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem
Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem
Status: Archived
mi
from
Boston, MA
Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem
Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem
Status: Archived
Updated: 1/1/1970
Children's Hospital
mi
from
Boston, MA
Single Comprehensive Ultrasound to Rule Out DVT in High-Risk Patients
Ultrasound-Sparing Strategy for Suspected DVT: A Prospective Clinical Cohort Study
Status: Archived
mi
from
Memphis, TN
Single Comprehensive Ultrasound to Rule Out DVT in High-Risk Patients
Ultrasound-Sparing Strategy for Suspected DVT: A Prospective Clinical Cohort Study
Status: Archived
Updated: 1/1/1970
Le Bonheur Children's Hospital
mi
from
Memphis, TN
Rosiglitazone and Metformin: Outcomes Trial in Nondiabetic Patients With Stable Coronary Syndromes (Romance) Pilot Study
A Single-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Combined Rosiglitazone/Metformin (Avandamet®) vs. Placebo on Serological Outcomes in Non-Diabetic Patients With Stable Coronary Syndromes
Status: Archived
mi
from
Murray, UT
Rosiglitazone and Metformin: Outcomes Trial in Nondiabetic Patients With Stable Coronary Syndromes (Romance) Pilot Study
A Single-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Combined Rosiglitazone/Metformin (Avandamet®) vs. Placebo on Serological Outcomes in Non-Diabetic Patients With Stable Coronary Syndromes
Status: Archived
Updated: 1/1/1970
Intermountain Medical Center
mi
from
Murray, UT
Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients
A Prospective, Randomized, Open-Label, Pilot Study To Compare The Effect On Carotid Atherosclerosis Of A Tacrolimus-Based Regimen With Conversion From A Tacrolimus- To A Sirolimus-Based Regimen At 3-4 Months Post-Transplant In De Novo Renal Transplant Recipients
Status: Archived
mi
from
Boston, MA
Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients
A Prospective, Randomized, Open-Label, Pilot Study To Compare The Effect On Carotid Atherosclerosis Of A Tacrolimus-Based Regimen With Conversion From A Tacrolimus- To A Sirolimus-Based Regimen At 3-4 Months Post-Transplant In De Novo Renal Transplant Recipients
Status: Archived
Updated: 1/1/1970
Massachusetts General Hospital
mi
from
Boston, MA
Interpersonal Psychotherapy for Depression in People With Heart Failure
Interpersonal Psychotherapy for Depression in Patients With Heart Failure
Status: Archived
mi
from
Iowa City, IA
Interpersonal Psychotherapy for Depression in People With Heart Failure
Interpersonal Psychotherapy for Depression in Patients With Heart Failure
Status: Archived
Updated: 1/1/1970
University of Iowa
mi
from
Iowa City, IA
The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes
The Efficacy and Short-Term Safety of Docosahexaenoic Acid (DHA) and Statin Therapy for Subjects With Coronary Artery Disease or Cardiac Risk Equivalents With Moderate Hypertriglyceridemia (IIb)
Status: Archived
mi
from
Scarborough, ME
The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes
The Efficacy and Short-Term Safety of Docosahexaenoic Acid (DHA) and Statin Therapy for Subjects With Coronary Artery Disease or Cardiac Risk Equivalents With Moderate Hypertriglyceridemia (IIb)
Status: Archived
Updated: 1/1/1970
Maine Center for Lipids and Cardiovascular Health
mi
from
Scarborough, ME
Safety and Efficacy of Autologous, Intracoronary Stem Cell Injections in Total Coronary Artery Occlusions
Safety and Efficacy of Autologous, Intracoronary Stem Cell Injections in Total Coronary Artery Occlusions
Status: Archived
mi
from
Cleveland, OH
Safety and Efficacy of Autologous, Intracoronary Stem Cell Injections in Total Coronary Artery Occlusions
Safety and Efficacy of Autologous, Intracoronary Stem Cell Injections in Total Coronary Artery Occlusions
Status: Archived
Updated: 1/1/1970
Case Western Reserve Univ
mi
from
Cleveland, OH
Study of the Arachidonate 5-Lipoxygenase Enzyme in Affecting the Risk for Coronary Heart Disease
Role of the Arachidonate 5-Lipoxygenase Pathway in Coronary Heart Disease
Status: Archived
mi
from
Gainesville, FL
Study of the Arachidonate 5-Lipoxygenase Enzyme in Affecting the Risk for Coronary Heart Disease
Role of the Arachidonate 5-Lipoxygenase Pathway in Coronary Heart Disease
Status: Archived
Updated: 1/1/1970
University of Florida Family Practice Medical Group Clinic
mi
from
Gainesville, FL
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Status: Archived
mi
from
Augusta, GA
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Status: Archived
Updated: 1/1/1970
Med College of Georgia
mi
from
Augusta, GA
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Status: Archived
mi
from
Worcester, MA
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Status: Archived
Updated: 1/1/1970
Umass Memorial Medical Center
mi
from
Worcester, MA
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Status: Archived
mi
from
Northport, NY
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Status: Archived
Updated: 1/1/1970
Northport VA Medical Center
mi
from
Northport, NY
Study of Carotid Occlusion and Neurocognition
Randomized Evaluation of Carotid Occlusion and Neurocognition (RECON)
Status: Archived
mi
from
New York, NY
Study of Carotid Occlusion and Neurocognition
Randomized Evaluation of Carotid Occlusion and Neurocognition (RECON)
Status: Archived
Updated: 1/1/1970
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Treatment of Ventricular Tachyarrhythmias Refractory To Shock With Beta Blockers: The SHOCK and BLOCK Trial
Treatment of Ventricular Tachyarrhythmias Refractory To Shock With Beta Blockers: The SHOCK and BLOCK Trial
Status: Archived
mi
from
Royal oak, MI
Treatment of Ventricular Tachyarrhythmias Refractory To Shock With Beta Blockers: The SHOCK and BLOCK Trial
Treatment of Ventricular Tachyarrhythmias Refractory To Shock With Beta Blockers: The SHOCK and BLOCK Trial
Status: Archived
Updated: 1/1/1970
Wiiliam Beaumont Hospital
mi
from
Royal oak, MI
A Study of the Effects of Minocycline on Cognitive Function After Carotid Endarterectomy
A Randomized, Placebo-Controlled Study of the Effects of Minocycline on Cognitive Function After Carotid Endarterectomy
Status: Archived
mi
from
Chestnut Hill, MA
A Study of the Effects of Minocycline on Cognitive Function After Carotid Endarterectomy
A Randomized, Placebo-Controlled Study of the Effects of Minocycline on Cognitive Function After Carotid Endarterectomy
Status: Archived
Updated: 1/1/1970
Brigham & Women's Hospital Women's Health Center
mi
from
Chestnut Hill, MA
Chronic Administration of Subcutaneous Brain Natriuretic Peptide (SQ BNP) on the Left Ventricular, Renal and Humoral Function and on the Integrated Response to Acute Sodium Loading
To Define in Human Preclinical Diastolic Dysfunction (PDD) the Actions of Chronic Administration of SQ BNP on the Left Ventricular, Renal and Humoral Function and on the Integrated Response to Acute Sodium Loading - Protocol III
Status: Archived
mi
from
Rochester, MN
Chronic Administration of Subcutaneous Brain Natriuretic Peptide (SQ BNP) on the Left Ventricular, Renal and Humoral Function and on the Integrated Response to Acute Sodium Loading
To Define in Human Preclinical Diastolic Dysfunction (PDD) the Actions of Chronic Administration of SQ BNP on the Left Ventricular, Renal and Humoral Function and on the Integrated Response to Acute Sodium Loading - Protocol III
Status: Archived
Updated: 1/1/1970
Mayo Clinic Rochester
mi
from
Rochester, MN
Human BNP (Nesiritide) to Help Heart, Kidney, and Hormonal Functions in Persons With Lower Heart Pumping Function
To Define in Human Preclinical Systolic Dysfunction (PSD) the Actions of Chronic Administration of Subcutaneous (SQ) BNP on the Left Ventricular, Renal, and Humoral Function and on the Integrated Response to Acute Sodium Loading
Status: Archived
mi
from
Rochester, MN
Human BNP (Nesiritide) to Help Heart, Kidney, and Hormonal Functions in Persons With Lower Heart Pumping Function
To Define in Human Preclinical Systolic Dysfunction (PSD) the Actions of Chronic Administration of Subcutaneous (SQ) BNP on the Left Ventricular, Renal, and Humoral Function and on the Integrated Response to Acute Sodium Loading
Status: Archived
Updated: 1/1/1970
Mayo Clinic Rochester
mi
from
Rochester, MN
Abnormal 3-D MRI Flow Patterns in Adolescents Patients With Bicuspid Aortic Valve
Abnormal 3-dimensional MRI Flow Patterns and Plasma Matrix Metalloproteinase Levels Predict Dilatation of Ascending Aorta in Adolescent Patients With Bicuspid Aortic Valve
Status: Archived
mi
from
Philadelphia, PA
Abnormal 3-D MRI Flow Patterns in Adolescents Patients With Bicuspid Aortic Valve
Abnormal 3-dimensional MRI Flow Patterns and Plasma Matrix Metalloproteinase Levels Predict Dilatation of Ascending Aorta in Adolescent Patients With Bicuspid Aortic Valve
Status: Archived
Updated: 1/1/1970
Children`s Hospital of Philadelphia : University of Philadelphia
mi
from
Philadelphia, PA
Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis
A Pilot Dose-Finding and Pharmacokinetic Study of Fondaparinux in Children With Deep Vein Thrombosis or Heparin-Induced Thrombocytopenia
Status: Archived
mi
from
Los Angeles, CA
Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis
A Pilot Dose-Finding and Pharmacokinetic Study of Fondaparinux in Children With Deep Vein Thrombosis or Heparin-Induced Thrombocytopenia
Status: Archived
Updated: 1/1/1970
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis
A Pilot Dose-Finding and Pharmacokinetic Study of Fondaparinux in Children With Deep Vein Thrombosis or Heparin-Induced Thrombocytopenia
Status: Archived
mi
from
Pittsburgh, PA
Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis
A Pilot Dose-Finding and Pharmacokinetic Study of Fondaparinux in Children With Deep Vein Thrombosis or Heparin-Induced Thrombocytopenia
Status: Archived
Updated: 1/1/1970
Children's Hospital
mi
from
Pittsburgh, PA
Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis
A Pilot Dose-Finding and Pharmacokinetic Study of Fondaparinux in Children With Deep Vein Thrombosis or Heparin-Induced Thrombocytopenia
Status: Archived
mi
from
Columbus, OH
Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis
A Pilot Dose-Finding and Pharmacokinetic Study of Fondaparinux in Children With Deep Vein Thrombosis or Heparin-Induced Thrombocytopenia
Status: Archived
Updated: 1/1/1970
Nationwide Children's Hospital in Columbus
mi
from
Columbus, OH
Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis
A Pilot Dose-Finding and Pharmacokinetic Study of Fondaparinux in Children With Deep Vein Thrombosis or Heparin-Induced Thrombocytopenia
Status: Archived
mi
from
Houston, TX
Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis
A Pilot Dose-Finding and Pharmacokinetic Study of Fondaparinux in Children With Deep Vein Thrombosis or Heparin-Induced Thrombocytopenia
Status: Archived
Updated: 1/1/1970
Texas Children's Hospital - Feigin Center
mi
from
Houston, TX
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
Status: Archived
mi
from
Bethesda, MD
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
Status: Archived
Updated: 1/1/1970
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Mechanism of Percutaneous Revascularization for Coronary Bifurcation Disease
Insights Into the Mechanism of Percutaneous Revascularization of Coronary Bifurcation Disease in the Drug-Eluting Stent Era. An Angiographic and Intravascular Ultrasound Study. The INSIGHT Trial
Status: Archived
mi
from
Jacksonville, FL
Mechanism of Percutaneous Revascularization for Coronary Bifurcation Disease
Insights Into the Mechanism of Percutaneous Revascularization of Coronary Bifurcation Disease in the Drug-Eluting Stent Era. An Angiographic and Intravascular Ultrasound Study. The INSIGHT Trial
Status: Archived
Updated: 1/1/1970
University of Florida Health Science Center - Jacksonville
mi
from
Jacksonville, FL
Redesigning Cardiac Surgery to Reduce Neurologic Injury
Redesigning Cardiac Surgery to Reduce Neurologic Injury
Status: Archived
mi
from
Portland, ME
Redesigning Cardiac Surgery to Reduce Neurologic Injury
Redesigning Cardiac Surgery to Reduce Neurologic Injury
Status: Archived
Updated: 1/1/1970
Maine Children's Medical Center
mi
from
Portland, ME
Redesigning Cardiac Surgery to Reduce Neurologic Injury
Redesigning Cardiac Surgery to Reduce Neurologic Injury
Status: Archived
mi
from
Darien, CT
Redesigning Cardiac Surgery to Reduce Neurologic Injury
Redesigning Cardiac Surgery to Reduce Neurologic Injury
Status: Archived
Updated: 1/1/1970
Darien Pediatric Associates
mi
from
Darien, CT
Redesigning Cardiac Surgery to Reduce Neurologic Injury
Redesigning Cardiac Surgery to Reduce Neurologic Injury
Status: Archived
mi
from
Manchester, NH
Redesigning Cardiac Surgery to Reduce Neurologic Injury
Redesigning Cardiac Surgery to Reduce Neurologic Injury
Status: Archived
Updated: 1/1/1970
Catholic Medical Center
mi
from
Manchester, NH
Oral Direct Factor Xa Inhibitor Rivaroxaban In Patients With Acute Symptomatic Pulmonary Embolism With Or Without Symptomatic Deep-Vein Thrombosis: Einstein-PE Evaluation
Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism
Status: Archived
mi
from
Little Rock, AR
Oral Direct Factor Xa Inhibitor Rivaroxaban In Patients With Acute Symptomatic Pulmonary Embolism With Or Without Symptomatic Deep-Vein Thrombosis: Einstein-PE Evaluation
Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Little Rock, AR
Oral Direct Factor Xa Inhibitor Rivaroxaban In Patients With Acute Symptomatic Pulmonary Embolism With Or Without Symptomatic Deep-Vein Thrombosis: Einstein-PE Evaluation
Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism
Status: Archived
mi
from
Santa Clara, CA
Oral Direct Factor Xa Inhibitor Rivaroxaban In Patients With Acute Symptomatic Pulmonary Embolism With Or Without Symptomatic Deep-Vein Thrombosis: Einstein-PE Evaluation
Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Santa Clara, CA
Oral Direct Factor Xa Inhibitor Rivaroxaban In Patients With Acute Symptomatic Pulmonary Embolism With Or Without Symptomatic Deep-Vein Thrombosis: Einstein-PE Evaluation
Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism
Status: Archived
mi
from
Denver, CO
Oral Direct Factor Xa Inhibitor Rivaroxaban In Patients With Acute Symptomatic Pulmonary Embolism With Or Without Symptomatic Deep-Vein Thrombosis: Einstein-PE Evaluation
Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Denver, CO
Oral Direct Factor Xa Inhibitor Rivaroxaban In Patients With Acute Symptomatic Pulmonary Embolism With Or Without Symptomatic Deep-Vein Thrombosis: Einstein-PE Evaluation
Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism
Status: Archived
mi
from
Celebration, FL
Oral Direct Factor Xa Inhibitor Rivaroxaban In Patients With Acute Symptomatic Pulmonary Embolism With Or Without Symptomatic Deep-Vein Thrombosis: Einstein-PE Evaluation
Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Celebration, FL
Oral Direct Factor Xa Inhibitor Rivaroxaban In Patients With Acute Symptomatic Pulmonary Embolism With Or Without Symptomatic Deep-Vein Thrombosis: Einstein-PE Evaluation
Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism
Status: Archived
mi
from
Atlanta, GA
Oral Direct Factor Xa Inhibitor Rivaroxaban In Patients With Acute Symptomatic Pulmonary Embolism With Or Without Symptomatic Deep-Vein Thrombosis: Einstein-PE Evaluation
Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Atlanta, GA